THE INSTITUTE FOR CANCER RESEARCH - COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS

PIID: 75N91023F00001

Signed Date: Jan 29, 2026Effective Date: Jul 10, 2023End Date: Closes in 254 days

Award $

$1.0M

Vendor

THE INSTITUTE FOR CANCER RESEARCH

NAICS

541714

Signed Date

Jan 29, 2026

Key Details

Dollars Obligated

$1.0M

Base & All Options

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

PHILADELPHIA, PA, 191114277, CD-PA-02

COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS

On Jan 29, 2026, Department of Health and Human Services obligated $1,038,958 to THE INSTITUTE FOR CANCER RESEARCH for colorectal cancer (crc) prevention by urolithin a in rodent crc models. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in PHILADELPHIA, PA. The contract is scheduled through Jul 9, 2027 — approximately 8 months remaining.